ARCHIVES

Two Papers Evaluate CyberKnife Survival Rates and Tolerability

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Shingleton To Retire As Director Of Duke Comprehensive Center

July 10, 1981

Program Project Scores Have Compressed Review Shuld Return To Rank Order; Broder

October 2, 1992

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001

Rogers-Kennedy Impasses Still Blocks Training Grant Bill

April 19, 1974

Flow Lab Lands Top Virology Contract – $1.9 Mil.

February 21, 1975

Biomedical Science Leadership is America’s Greatest Contribution, Benno Schmidt Says

August 14, 1987